Associated Press logo
Axios logo
MSNBC logo
5 articles
·4M

Federal Court Upholds Elizabeth Holmes' Fraud Conviction in Theranos Scandal

Elizabeth Holmes loses appeal to overturn her fraud conviction, upholding her 11-year sentence for deceiving investors about Theranos' blood-testing technology.

Overview

A summary of the key points of this story verified across multiple sources.

The Ninth Circuit Court of Appeals has upheld Elizabeth Holmes' fraud conviction for misleading investors about her blood-testing startup, Theranos. The court also affirmed the conviction of Ramesh 'Sunny' Balwani, with both defendants ordered to repay $452 million in restitution. Holmes, serving an 11-year sentence, argued that legal errors occurred during her trial, but the court found these claims unsubstantiated. The ruling leaves options for further appeal, possibly to the U.S. Supreme Court. Holmes' case remains a significant example of fraud in Silicon Valley, with widespread media coverage following the company's downfall.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Analysis unavailable for this viewpoint.

Articles (5)

Compare how different news outlets are covering this story.

Center (2)

FAQ

Dig deeper on this story with frequently asked questions.

Elizabeth Holmes was convicted of one count of conspiracy to commit fraud on investors and three counts of committing fraud on individual investors, involving wire transfers totaling more than $140 million.

Elizabeth Holmes can file a new appeal to all judges on the Ninth Circuit Court of Appeals or even petition the U.S. Supreme Court.

Elizabeth Holmes and Ramesh 'Sunny' Balwani are jointly required to pay $452 million in restitution.

The appeals court found that any alleged errors during the trials were harmless and did not violate the defendants' constitutional rights. The court also noted that Theranos employees had raised concerns about the reliability of the company's testing technology, which were dismissed by Holmes and Balwani.

History

See how this story has evolved over time.

  • This story does not have any previous versions.